Introduction
First described by Dr. Sweet in 1964 [ 1 ] , Sweet's syndrome (SS) is characterized by a constellation of fi ndings that include painful erythematous plaques and a dense dermal neutrophilic infi ltrate, which may be associated with fever, neutrophilia, leukocytosis, and a dramatic response to systemic corticosteroids [ 2 ] . In 1986, Su and Liu [ 3 ] proposed a set of major and minor criteria for the diagnosis of SS. Following the review of data from 38 patients, von den Driesch [ 4 ] published a modifi cation of these diagnostic criteria in 1994 (Table 1 ) , according to which both major criteria and two minor criteria were required for SS to be diagnosed. In 1996, Walker and Cohen [ 5 ] proposed individual diagnostic criteria for drug-induced SS ( Table 2 ) .
As evidenced by the available literature, the diagnosis of SS generally seems to be based on the aforementioned current criteria [ 4 ] ; in some cases, however, the diagnosis is not as straightforward, potentially resulting in delayed diagnosis. Moreover, published reports show the absence of certain criteria as well as non-inclusion of some emerging variants, thus highlighting the need for more precise diagnostic criteria [ 2, [6] [7] [8] [9] [10] [11] .
Herein, we review the various clinical, laboratory, and histopathological aspects of the current diagnostic criteria for SS, evaluate their validity in the reported literature and in 40 (new) patients treated at our institution, and subsequently propose a modifi cation of said criteria.
Patients and methods
The study included 40 patients with SS who attended the Dermatology Outpatient Clinic at Zagazig University Hospital from January 2012 to January 2016. Initially, a detailed history was taken. All individuals were then subjected to a thorough dermatological and clinical examination, histopathological studies, and detailed workup for any associated disorders. In addition, patients were assessed for laboratory abnormalities, type and response to treatment, as well as potential recurrences. Finally, the validity of the current criteria in the diagnosis of our cases as well as in the reported literature was also evaluated.
Results
The study included 40 adult individuals: 32 (70 %) women and eight (30 %) men (Table 3 ) . Patient age ranged from 28 to 65 years. Thirty-two (80 %) patients had classic SS; six (15 %) had an underlying malignancy; two (5 %) cases were associated with drug intake. Clinically, all patients presented with abrupt onset of painful or tender erythematous papules, plaques or nodules on the hands, face, neck, and upper extremities (Figure 1 a, b) . In eight patients, the lesions were associated with overlying pustules (Figure 1 c) , vesicles, or blisters (Figure 1 d) . Similarly, all individuals showed a "dense dermal neutrophilic infi ltrate without leukocytoclastic vasculitis" (Figure 2 ) on histology. Other rare histopathological features such as "subcutaneous" and "histiocytoid" variants were not detected in any of the patients. Variable fi ndings included fever, elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels, anemia, leukocytosis and neutrophilia. While all of our patients fulfi lled the two major criteria, only 25 individuals also showed two minor criteria. The majority of patients examined (35/40) were successfully treated with systemic corticosteroids at a dose of 40-60 mg/day, which was subsequently tapered over a period of 3-6 weeks. Those who did not tolerate systemic corticosteroids were successfully treated with dapsone 100 mg/ day (three patients) and colchicine 2 mg/day (two patients). Recurrence was reported in fi ve patients (12.5 %) within six weeks to six months after remission.
Discussion
The diagnosis of Sweet's syndrome is important not only in terms of detecting an underlying disorder but also with respect to prompt initiation of adequate treatment. In this context, the use of simple, precise, and clinically applicable diagnostic criteria seems plausible [ 7 ] . As modifi cation to the existing criteria [ 3, 4 ] , we propose two sets of diagnostic criteria (Table 4 ) meant to simplify the diagnosis, defi ne the disease more precisely, and allow for early diagnosis and thus prompt treatment of this acute disorder. The fi rst set comprises constant clinical and histopathological features that are always present. The second set includes variable clinical, histopathological, and laboratory features that have been reported in some patients and to which any fi nding -yet to emerge -might be added. The signifi cance of these variable features is to draw the attention of clinicians to the varying presentations of SS and to help avoid misdiagnosis.
Major criteria (constant features)
A review of the literature shows that -irrespective of underlying etiology or association -two main features have been consistently present in all reported SS cases since the fi rst description by Sweet in 1964, including the patients in our study cohort [ 3, 8, [12] [13] [14] [15] [16] [17] . The fi rst criterion is the clinical presentation of "abrupt onset of painful or tender erythematous papules, plaques, or nodules". The second feature is the histological fi nding of a "dense, predominantly neutrophilic dermal infi ltrate" [1] [2] [3] [4] . We therefore propose that the presence of these two features be a sine qua non and entirely suffi cient for the diagnosis of SS to be established, even in the absence of two minor criteria. Consequently, we prefer to describe these fi ndings as "constant features" instead of "major criteria" as the term "constant" implies the absolute presence of these features in SS. The term "major", on the other hand, does not necessarily imply their constant presence in every case, despite it being required, and also stands in contrast to the current criteria [ 4 ] , which require the presence of both major criteria for the diagnosis of SS. We therefore believe
In this respect, pain or tenderness was only reported in 26 % of patients studied by Marcoval et al. (36/138 patients) [ 18 ] , and in 43 % of individuals studied by Rochet et al. (33/77) [ 2 ] . This is a remarkable fi gure, given that the authors of these large case series reported that their patients fulfi lled the current diagnostic criteria for SS [ 4 ] , although, in fact, one of the two major criteria "tender or painful erythematous plaques or nodules" was missing in a large number of cases.
This raises the question about the accurate diagnosis of SS in both studies. It is well established that SS is a painful disorder, which cannot be diagnosed without the presence of pain or tenderness [ 19 ] . Therein lies the signifi cance of the newly proposed term "constant features" as it draws the attention of clinicians to the fact that these features are required for the diagnosis of SS.
One of the diagnostic challenges and controversial issues associated with SS is the signifi cance of leukocytoclastic vasculitis in the histological diagnosis. In the current diagnostic criteria, von den Driesch [ 4 ] made the absence of "leukocytoclastic vasculitis" a sine qua non for the diagnosis of SS. This criterion was fulfi lled in the present study, in the original eight cases published by Dr. Sweet, and in many other studies including the most recent article by Casarin Costa et al. [ 20 ] who reported the absence of leukocytoclastic vasculitis in their cohort of 83 patients. On the other hand, other authors have reported leukocytoclastic vasculitis in a variable number of patients, including Rochael et al. [ 22 ] . It has been postulated that -rather than a primary immune-mediated process -vasculitis in SS is a sign of secondary vascular damage resulting from noxious products released from the dense neutrophilic infi ltrate. This notion has been supported by two fi ndings: 1) blood vessels in lesions of longer duration are more likely to develop vasculitis than those in lesions of shorter duration, likely due to prolonged exposure to noxious metabolites; 2) immunofl uorescence studies show no immunoglobulin and complement deposition in the affected blood vessels. Many authors have therefore concluded that the presence of vasculitis ought not to rule that the term "constant features" is more appropriate than "major criteria" as it renders the diagnostic criteria more precise and better defi ned.
out the diagnosis of SS unless there is evidence of primary immune-mediated vasculitis [ 15, [22] [23] [24] . In this context, we believe that the clinical features of SS are critical for the diagnosis as the presence of typical SS lesions strongly suggests vasculitis -reported in some cases of SS -to be a secondary event, given that primary immune-mediated leukocytoclastic vasculitis presents with lesions clinically completely different from those observed in SS. In order to avoid any confusion regarding this controversial issue, we include "leukocytoclastic vasculitis" as a variable histopathological feature, and modify the second constant feature in our revised diagnostic criteria to "dense dermal neutrophilic infi ltrate".
Minor criteria (variable features)
On the other hand, minor SS criteria including fever, laboratory abnormalities (three out of four), and associated or underlying disorders have been variably reported in different studies. In a multicenter study from the UK, Bourke et al. [ 25 ] reported that 44 % of patients had fever; 51 %, neutrophilia; 44 %, leukocytosis; and 63 %, an elevated ESR. Similarly, Abbas et al. [ 8 ] observed fever in 70 % of their patients; neutrophilia, in 55 %; leukocytosis, in 55 %; and an elevated ESR in 60 %.
Moreover, El-Khalawany et al. [ 26 ] recently reported that genetic abnormalities might play a role in altering the classic nature of the disease, including the minor criteria such as fever, neutrophilic leukocytosis, and response to corticosteroids. In line with this concept, Jo et al. [ 10 ] have argued that the presence or absence of fever in SS depends on genetic susceptibility and is not an essential feature for the diagnosis of SS. These studies and many others [ 2, 6, 9, 11 ] confi rm the highly variable nature of these criteria and suggest that their absence does not warrant ruling out the diagnosis of SS.
Furthermore, the fi rst minor criterion includes "underlying disorders", rather than specifi c clinical, histopathological, or laboratory features. In particular, this applies to cases associated with malignancies, which may be discovered a long time after the diagnosis of SS [ 12, 16 ] . In addition, there is such a vast -and continually rising -number of associations that considering all of them as "a diagnostic criterion" is impractical. We therefore propose it be removed from the list of diagnostic criteria.
Also, the fourth minor criterion "dramatic response to systemic corticosteroids or potassium iodide" is a retrospective feature that does not help in the prospective diagnosis of a highly painful disorder that -rather than waiting for a therapeutic response to confi rm the clinical suspicionrequires prompt diagnosis and immediate treatment. Besides, systemic corticosteroids are associated with well-known hazards that make their use without confi rmed diagnosis inadvisable. Furthermore, a number of recent reports showed an absent or poor response to systemic corticosteroids in some cases of SS (steroid-refractory SS); here, some authors described an excellent response to other drugs such as colchicine [ 12-16, 26, 27 ] . Therefore, we argue against including this item as "a minor criterion" for the diagnosis of SS, which has to be established prior to treatment initiation. Based on these observations and studies, we propose changing the term "minor criteria" to "variable features" in order to better refl ect the variable nature of these features, which are not present in every case and whose absence ought not to exclude the diagnosis of SS. Accordingly, we consider all of our cases to represent SS, despite the absence of two minor criteria in 15 of them. We also believe that the use of the term "variable features" would help avoid missing those cases in which the requirement of two minor criteria is not met. Moreover, it would avoid any delay resulting from the adherence to unnecessary criteria, thus enabling prompt treatment. This is particularly critical in cases associated with malignancy and in drug-induced SS, where strict application of the current minor criteria might lead to serious and irreversible consequences [ 12 ] .
We also suggest further subdivision of these variable characteristics into clinical, histopathological, and laboratory features in order to be able to encompass the various presentations of SS as well as any new features yet to emerge. Thus, atypical clinical presentations such as pustular vasculitis-like lesions, pyoderma gangrenosum-like lesions [ 15, 28, 29 ] , and giant cellulitis-like lesions [ 30 ] , as well as uncommon histological manifestations such as subcutaneous SS [ 31 ] , histiocytoid SS [ 32, 33 ] , xanthomatoid SS [ 34 ] , and cryptococcoid SS [ 35 ] may be included in the "variable features" of our revised criteria to draw the attention of clinicians to these rare presentations.
Clinical applications
Many fi ndings and observations in the present study as well as in the available literature support our view that the presence of "two minor criteria" is not required for the diagnosis of SS. In our study, 15 out of 40 patients showed the two major or constant features of SS without fulfi lling the requirement of also exhibiting two minor criteria. In this context, it is noteworthy that said requirement was not met, either, by two patients (cases No. 1, 2) in the original eight cases studied by Sweet [ 1 ] . The fact that application of the current diagnostic criteria would not have included all patients in the original series raises questions about their validity [ 4 ] . Furthermore, following his own re-evaluation of the signifi cance of the minor criteria in the diagnosis of SS in 1979, Sweet concluded that "they did not represent an essential part of the clinical picture as he had fi rst considered" [ 36 ] .
Similarly, two of the fi ve cases (no. 2 and 4) of acral SS described by Abbas et al. [ 8 ] did not meet the requirement of showing two minor criteria, although they had been diagnosed as having SS based on current diagnostic criteria. The same observation was also made in the cases reported by Batron et al. [ 6 ] (two out of three) and Kassardjian et al. [ 37 ] (one case) in which the diagnosis of SS was established without fulfi lling two minor criteria (no fever at presentation, no underlying cause detected, and three out of four laboratory features not present). In their report of two SS cases, Gowda et al. [ 38 ] mentioned that their patients showed typical clinical, histopathological, and laboratory features. However, this was not actually the case as one of the major criteria (no pain or tenderness) and the requirement of two minor criteria were not fulfi lled.
In agreement with our modifi cations, which render the "constant features" entirely suffi cient for the diagnosis of SS to be established, Romero et al. [ 39 ] and Vij et al. [ 40 ] reported a total of fi ve cases of afebrile chronic, recurrent SS without leukocytosis or neutrophilia at any time during the several-years long disease course. Over that entire period, the patients never fulfi lled the criteria suffi cient for a defi nitive diagnosis of SS as initially proposed by Su and Liu [ 3 ] and revised by von den Driesch [ 4 ] ; while the two major criteria were met during disease fl are-ups, the required two minor criteria were never fulfi lled.
Very recently, Ferris et al. [ 34 ] described an interesting, unique case of SS characterized by the presence of many xanthomatoid cells and called it "xanthomatoid variant of SS". Here, the two major criteria were met, whereas the requirement of showing two minor criteria was not fulfi lled.
Given the absence of the two minor criteria, none of the aforementioned cases ought to have been diagnosed as SS according to the current diagnostic criteria [ 4 ] . However, they were considered to be SS (by the authors) as they fulfi lled the two major (constant) criteria. We agree with our colleagues and believe that the application of our revised criteria would help avoid missing certain cases as a result of adhering to the unnecessary minor features of the current diagnostic criteria.
In accordance with our concept, Ginarte and Toribio [ 16 ] have also pointed out that the current criteria [ 4 ] are not generally accepted due to the presence of many atypical cases of SS that cannot be classifi ed according to these criteria. The presence of the term "variable features" in our revised criteria might encompass these atypical clinical or histopathological presentations and any new features or manifestations yet to emerge.
Diagnostic criteria for drug-induced SS
In 1996, Walker and Cohen [ 5 ] proposed a set of fi ve criteria required for the diagnosis of drug-induced SS.
Here, the authors confi rmed the necessity of the two major criteria to be present and added three more features including fever; coincidentally, their patient had already been febrile prior to the use of trimethoprim-sulfamethoxazole for the treatment of an acute episode of diarrhea. We do not agree with these criteria and believe that fever is a variable feature whose absence ought not to rule out the diagnosis of SS irrespective of the underlying cause, no matter if drug-related or not [ 2, 8, 12, 26 ] . This would help avoid missing cases that do not present with fever. In this context, many authors have reported cases of drug-induced SS without fever, which did, however, show the two "constant features" (thalidomide-induced SS) [ 9 ] , (topotecan-induced SS) [ 41 ] , (minocycline-induced SS) [ 42 ] , and (ipilimumab-induced SS) [ 43 ] .
Moreover, criterion no. 5 "temporally related resolution of lesions following drug withdrawal or treatment with systemic corticosteroids" is a retrospective diagnostic criterion that -similar to classic SS -cannot be used as a sine qua non in the prospective diagnosis.
Based on the previous observations, we believe that there is no need to establish specifi c diagnostic criteria for drug-induced SS. Not doing so will help avoid confusion and misdiagnosis due to strict adherence to unnecessarily rigid criteria. We propose that our revised criteria may be used for all subtypes of SS, including the drug-induced variant.
In summary, we propose a) that the term "major criteria" be changed to "constant features", which are always required for the diagnosis of SS to be established, and b) that the term "minor criteria" be changed to "variable features", whose absence does not warrant ruling out SS. Consequently, we suggest that the abrupt onset of painful erythematous plaques or nodules in association with a dense dermal neutrophilic infi ltrate be suffi cient to confi rm the diagnosis of SS; this applies even in the absence of any variable features and irrespective of any underlying disorder or the clinical subtype of SS. We also propose that clinicians should not adhere to the requirement of "two minor criteria" being present as a sine qua non for the diagnosis of SS. This will help avoid misdiagnosis of this extremely painful and stressful disorder, and allow for rapid diagnosis and consequently prompt treatment.
